tirzepatide v semaglutide side effects vs Tirzepatide vs Semaglutide | Heal

Concomitant diseases included heart failure (23%), hypertension (91%), previous ischemic stroke (12%), previous MI (40%), and peripheral artery disease (16%)

VinuNavarroJHerrero-CerveraAGarca-CubasMAndrs-BlascoIMartnez-HervsSet alThe GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype

Semaglutide copies the effects of GLP-1

The work was supported by a Diabetes UK RD Lawrence Fellowship to Dr Reshma Ramracheya, a Novo Nordisk University of Oxford postdoctoral fellowship to Dr Claudia Guida and an OXION Wellcome Trust studentship to Miss Joely Kellard

da Silva LE, de Oliveira MP, da Silva MR, Abel JdS, Tartari G, de Aguiar da Costa M, et al